The health data analytics provider's series E round was co-led by Kaiser Permanente Group Trust at a $1bn valuation and also featured McKesson Ventures.
Healthcare consortium Kaiser Permanente’s Group Trust co-led a $153m series E round for US-based health data analysis provider Evidation Health on Monday.
The round was co-led by Omers Growth Equity, a fund managed by pension fund Ontario Municipal Employees Retirement System, and included McKesson Ventures, the corporate venturing arm of medical supplies distributor McKesson, as well as venture capital firm B Capital Group.
Evidation’s technology platform, Achievement, records raw behaviour data such as speech and video from patients’ electronic devices…
